Key result
This review provides an overview of available platelet function and genetic tests for monitoring clopidogrel responsiveness and discusses their potential clinical utility and routine application.
Population
Patients receiving anti-P2Y12 therapy (clopidogrel)
Design
Review
Authors
Loading...
May identify clopidogrel poor responders for tailored therapy; leaves open routine clinical adoption pending outcome trials.
This review highlights the potential of platelet function and genetic testing to identify poor responders to clopidogrel and tailor anti-P2Y12 therapy, though their routine clinical utility remains uncertain.
Paul Harrison (2012) conducted a review in Clopidogrel responsiveness. Platelet function and genetic tests was evaluated. This review provides an overview of available platelet function and genetic tests for monitoring clopidogrel responsiveness and discusses their potential clinical utility and routine application.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: